BERTOLACCINI, LUCA
BERTOLACCINI, LUCA
Dipartimento di Oncologia ed Emato-Oncologia
The Actual Role of CPET in Predicting Postoperative Morbidity and Mortality of Patients Undergoing Pneumonectomy
2025 A. Mazzella, R. Orlandi, P. Maisonneuve, C. Uslenghi, M. Chiari, M. Casiraghi, L. Bertolaccini, G. Caffarena, L. Spaggiari
Small Nodules and Big Questions: A Closer Look at the RELIANT Trial
2025 L. Bertolaccini, C. Bardoni, J. Guarize
Diverging trends in lung cancer: a 26-year analysis of sex-specific patterns and histological shifts in Northern Italy
2025 L. Bertolaccini, C. Santucci, C. La Vecchia, F. Toffolutti, G. Corso, L. Spaggiari, D. Serraino
239P Dual AI models for perioperative decision support in resectable NSCLC: A real-world cohort analysis
2025 C. Bardoni, L. Bertolaccini, J. Guarize, M. Casiraghi, G. Lo Iacono, M. Chiari, C. Diotti, A. Mazzella, S.M. Donghi, R. Gasparri, S. Mohamed, V.A. Artuso, G. Caffarena, L. Spaggiari
Raising the bar: evaluating quality and consistency in clinical guidelines for surgical management of pulmonary carcinoid
2025 L. Bertolaccini, C. Bardoni, G. Caffarena, M. Chiari, C. Diotti, A. Mazzella, L. Benini, F. Spada, G. Corso, E. Pisa, M. Casiraghi, N. Fazio, L. Spaggiari
Reflections on the ThoRN Consensus: Toward a Multidisciplinary Integration
2025 L. Bertolaccini, C. Bardoni, M. Casiraghi, L. Spaggiari
Identification and validation of diagnostic alternative splicing events in tumor-educated platelets for non-small cell lung cancer in patients with ground-glass opacity: a multicenter study
2025 M. Shao, W. Li, J. Cao, L. Wang, S. Xie, Y. Hu, G. Feng, F. Azari, L. Bertolaccini, W. Liu, B. He
10-Year Long-Term Outcomes of Robotic-Assisted Segmentectomy for Early-Stage Non-Small-Cell Lung Cancer
2025 M. Casiraghi, R. Orlandi, A. Mazzella, L. Girelli, G. Caffarena, M. Chiari, L. Bertolaccini, G. Lo Iacono, C. Diotti, C. Bardoni, P. Maisonneuve, L. Spaggiari
Vetus Sed Utilis: Open Window Thoracostomy after Lung Surgery
2025 A. Mazzella, C. Bardoni, L. Bertolaccini, M. Casiraghi, L. Girelli, G.L. Iacono, L. Spaggiari
Diaphragmatic plication for diaphragmatic paralysis: A systematic review and meta-analysis of surgical outcomes
2025 M. Rahouma, S. Al-Thani, M. Baudo, S. Khairallah, I. El-Kharbotly, A. Dabsha, K. Mehta, M. El-Sherbiny, J. Port, S.L. Mick, L. Bertolaccini
Clinicopathological Features and Prognosis of Lung Adenocarcinoma Presenting as Ground-Glass Opacity: A Single-Center Experience
2025 M. Casiraghi, L. Girelli, A. Elettore, L. Bertolaccini, A. Mazzella, C. Bardoni, M. Lombardi, V. Midolo, G. Petralia, P. Maisonneuve, J. Guarize, L. Spaggiari
Safety and Efficacy of Salvage Surgery after Treatment With Immune-Checkpoint Adjuvant Inhibitors for Advanced Non-Small Cell Lung Cancer: A Multicentric Study
2025 M. Schiavon, G. Cannone, L. Bertolaccini, F.T. Gallina, F. Pezzuto, G. Lorenzoni, F. Facciolo, L. Spaggiari, F. Calabrese, F. Rea, G. Pasello
Unlocking the depths: the evolution of robotic-assisted bronchoscopy
2025 J. Guarize, L. Bertolaccini
T4-non-small cell lung cancer invading the thoracic aorta: the role of the hybrid operating room
2025 F. Zaraca, M.D. Pipitone, G. Coppi, B. Feil, L.F. Milazzo, G. Zaraca, R. Perkmann, A. Kirschbaum, C. Bardoni, L. Bertolaccini
Redefining resectability: Bridging perspectives in stage III NSCLC management
2025 L. Bertolaccini, M. Casiraghi, A. Mazzella, L. Spaggiari
Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis
2025 L. Bertolaccini, G. Caffarena, F. Spada, L. Benini, E. Pisa, R. Lobrano, M. Chiari, V. Midolo De Luca, J. Guarize, M. Casiraghi, N. Fusco, N. Fazio, L. Spaggiari
Unmasking the mimic: lipoid pneumonia imitating primary lung cancer - a case report series of a diagnostic challenge
2025 S. Mohamed, L. Bertolaccini, M. Lombardi, C. Di Tonno, A. Sabalic, M. Casiraghi, L. Spaggiari
Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma: signal or noise?
2025 L. Bertolaccini, F. De Marinis, L. Spaggiari
Biological staging in early-stage non-small-cell lung cancer: molecular risk-guided adjuvant therapy
2025 L. Bertolaccini, L. Spaggiari
Bridging the divide: Addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilization
2025 D. Horgan, P. Hofman, R. Buttner, O. Riess, I. Lugowska, F. Dube, J. Singh, E. Nadal, T. Stoklosa, E. Sivina, M. Van Der Buckle, S. Mosoiu, L. Bertolaccini, N. Girard, J.V. Meerbeeck, I. Omar, E.D. Capoluongo, S. Bielack, T. Hills, D. Baldwin, V. Subbiah